Clinical trial
Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy
NCT00411333 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy
- Lead sponsor
- National Eye Institute (NEI)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2006
- Completion date
- July 31, 2009
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.